{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:20:22Z","timestamp":1777998022828,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,25]]},"DOI":"10.7759\/cureus.77981","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T20:02:17Z","timestamp":1737835337000},"source":"Crossref","is-referenced-by-count":1,"title":["An Update on the Role of Lymphatic Function in Skin Inflammatory Disorders: A Scoping Review"],"prefix":"10.7759","author":[{"given":"Irina","family":"Ter-Ovanesyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Tashjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Escruceria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryant","family":"Estadella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey N","family":"Mayrovitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201928","article-title":"VEGF\/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development","volume":"17","author":"Larcher F","year":"1998","unstructured":"Larcher F, Murillas R, Bolontrade M, Conti CJ, Jorcano JL. VEGF\/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene. 1998, 17:303-11. 10.1038\/sj.onc.1201928","journal-title":"Oncogene"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/micc.12031","article-title":"Lymphatic filariasis: perspectives on lymphatic remodeling and contractile dysfunction in filarial disease pathogenesis","volume":"20","author":"Chakraborty S","year":"2013","unstructured":"Chakraborty S, Gurusamy M, Zawieja DC, Muthuchamy M. Lymphatic filariasis: perspectives on lymphatic remodeling and contractile dysfunction in filarial disease pathogenesis. Microcirculation. 2013, 20:349-64. 10.1111\/micc.12031","journal-title":"Microcirculation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2613.2009.00669.x","article-title":"Angiogenesis drives psoriasis pathogenesis","volume":"90","author":"Heidenreich R","year":"2009","unstructured":"Heidenreich R, R\u00f6cken M, Ghoreschi K. Angiogenesis drives psoriasis pathogenesis. Int J Exp Pathol. 2009, 90:232-48. 10.1111\/j.1365-2613.2009.00669.x","journal-title":"Int J Exp Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2174\/1871530315666150316121956","article-title":"VEGF-VEGFR system as a target for suppressing inflammation and other diseases","volume":"15","author":"Shibuya M","year":"2015","unstructured":"Shibuya M. VEGF-VEGFR system as a target for suppressing inflammation and other diseases. Endocr Metab Immune Disord Drug Targets. 2015, 15:135-44. 10.2174\/1871530315666150316121956","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124850","article-title":"Antibody-mediated delivery of VEGF-C potently reduces chronic skin inflammation","volume":"3","author":"Schwager S","year":"2018","unstructured":"Schwager S, Renner S, Hemmerle T, et al.. Antibody-mediated delivery of VEGF-C potently reduces chronic skin inflammation. JCI Insight. 2018, 3:e124850. 10.1172\/jci.insight.124850","journal-title":"JCI Insight"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2013.10.006","article-title":"The VEGF-C\/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function","volume":"73","author":"Hagura A","year":"2014","unstructured":"Hagura A, Asai J, Maruyama K, Takenaka H, Kinoshita S, Katoh N. The VEGF-C\/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function. J Dermatol Sci. 2014, 73:135-41. 10.1016\/j.jdermsci.2013.10.006","journal-title":"J Dermatol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1089\/lrb.2013.0012","article-title":"Lymphatic function and immune regulation in health and disease","volume":"11","author":"Liao S","year":"2013","unstructured":"Liao S, Padera TP. Lymphatic function and immune regulation in health and disease. Lymphat Res Biol. 2013, 11:136-43. 10.1089\/lrb.2013.0012","journal-title":"Lymphat Res Biol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1087-0024.2000.00001.x","article-title":"Structure, function, and molecular control of the skin lymphatic system","volume":"5","author":"Skobe M","year":"2000","unstructured":"Skobe M, Detmar M. Structure, function, and molecular control of the skin lymphatic system. J Investig Dermatol Symp Proc. 2000, 5:14-9. 10.1046\/j.1087-0024.2000.00001.x","journal-title":"J Investig Dermatol Symp Proc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/jidsymp.2011.5","article-title":"The cutaneous vascular system in chronic skin inflammation","volume":"15","author":"Huggenberger R","year":"2011","unstructured":"Huggenberger R, Detmar M. The cutaneous vascular system in chronic skin inflammation. J Investig Dermatol Symp Proc. 2011, 15:24-32. 10.1038\/jidsymp.2011.5","journal-title":"J Investig Dermatol Symp Proc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222112035","article-title":"Angiogenesis in chronic inflammatory skin disorders","volume":"22","author":"Lee HJ","year":"2021","unstructured":"Lee HJ, Hong YJ, Kim M. Angiogenesis in chronic inflammatory skin disorders. Int J Mol Sci. 2021, 22:12035. 10.3390\/ijms222112035","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00308","article-title":"Inflammation and lymphatic function","volume":"10","author":"Schwager S","year":"2019","unstructured":"Schwager S, Detmar M. Inflammation and lymphatic function. Front Immunol. 2019, 10:308. 10.3389\/fimmu.2019.00308","journal-title":"Front Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0023","article-title":"Lymphatic vessels, inflammation, and immunity in skin cancer","volume":"6","author":"Lund AW","year":"2016","unstructured":"Lund AW, Medler TR, Leachman SA, Coussens LM. Lymphatic vessels, inflammation, and immunity in skin cancer. Cancer Discov. 2016, 6:22-35. 10.1158\/2159-8290.CD-15-0023","journal-title":"Cancer Discov"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI71610","article-title":"Lymphatic transport of high-density lipoproteins and chylomicrons","volume":"124","author":"Randolph GJ","year":"2014","unstructured":"Randolph GJ, Miller NE. Lymphatic transport of high-density lipoproteins and chylomicrons. J Clin Invest. 2014, 124:929-35. 10.1172\/JCI71610","journal-title":"J Clin Invest"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2022.864860","article-title":"Structural and functional changes in aged skin lymphatic vessels","volume":"3","author":"Kataru RP","year":"2022","unstructured":"Kataru RP, Park HJ, Shin J, Baik JE, Sarker A, Brown S, Mehrara BJ. Structural and functional changes in aged skin lymphatic vessels. Front Aging. 2022, 3:864860. 10.3389\/fragi.2022.864860","journal-title":"Front Aging"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.05.039","article-title":"Lymphatic dysfunction exacerbates cutaneous tumorigenesis and psoriasis-like skin inflammation through accumulation of inflammatory cytokines","volume":"142","author":"Boki H","year":"2022","unstructured":"Boki H, Kimura T, Miyagaki T, et al.. Lymphatic dysfunction exacerbates cutaneous tumorigenesis and psoriasis-like skin inflammation through accumulation of inflammatory cytokines. J Invest Dermatol. 2022, 142:1692-1702.e3. 10.1016\/j.jid.2021.05.039","journal-title":"J Invest Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.03.041","article-title":"Angiogenesis and lymphangiogenesis in inflammatory skin disorders","volume":"73","author":"Varricchi G","year":"2015","unstructured":"Varricchi G, Granata F, Loffredo S, Genovese A, Marone G. Angiogenesis and lymphangiogenesis in inflammatory skin disorders. J Am Acad Dermatol. 2015, 73:144-53. 10.1016\/j.jaad.2015.03.041","journal-title":"J Am Acad Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14151","article-title":"Vascular endothelial growth factor-A as a promising therapeutic target for the management of psoriasis","volume":"29","author":"Luengas-Martinez A","year":"2020","unstructured":"Luengas-Martinez A, Hardman-Smart J, Paus R, Young HS. Vascular endothelial growth factor-A as a promising therapeutic target for the management of psoriasis. Exp Dermatol. 2020, 29:687-98. 10.1111\/exd.14151","journal-title":"Exp Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100559","article-title":"Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation","volume":"207","author":"Huggenberger R","year":"2010","unstructured":"Huggenberger R, Ullmann S, Proulx ST, Pytowski B, Alitalo K, Detmar M. Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation. J Exp Med. 2010, 207:2255-69. 10.1084\/jem.20100559","journal-title":"J Exp Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/ced\/llac047","article-title":"Cutaneous vascular structure and perfusion in patients with chronic plaque psoriasis","volume":"48","author":"Luengas-Martinez A","year":"2023","unstructured":"Luengas-Martinez A, Kamaly-Asl A, Chaudhry IH, Brenchley PE, Young HS. Cutaneous vascular structure and perfusion in patients with chronic plaque psoriasis. Clin Exp Dermatol. 2023, 48:181-7. 10.1093\/ced\/llac047","journal-title":"Clin Exp Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2015.283","article-title":"Lymphatic function regulates contact hypersensitivity dermatitis in obesity","volume":"135","author":"Savetsky IL","year":"2015","unstructured":"Savetsky IL, Albano NJ, Cuzzone DA, et al.. Lymphatic function regulates contact hypersensitivity dermatitis in obesity. J Invest Dermatol. 2015, 135:2742-52. 10.1038\/jid.2015.283","journal-title":"J Invest Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2021.08.018","article-title":"Vascular endothelial growth factor as an immediate-early activator of ultraviolet-induced skin injury","volume":"97","author":"Hartono SP","year":"2022","unstructured":"Hartono SP, Bedell VM, Alam SK, et al.. Vascular endothelial growth factor as an immediate-early activator of ultraviolet-induced skin injury. Mayo Clin Proc. 2022, 97:154-64. 10.1016\/j.mayocp.2021.08.018","journal-title":"Mayo Clin Proc"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03692-0","article-title":"Heterogeneity in VEGFR3 levels drives lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms","volume":"9","author":"Zhang Y","year":"2018","unstructured":"Zhang Y, Ulvmar MH, Stanczuk L, Martinez-Corral I, Frye M, Alitalo K, M\u00e4kinen T. Heterogeneity in VEGFR3 levels drives lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms. Nat Commun. 2018, 9:1296. 10.1038\/s41467-018-03692-0","journal-title":"Nat Commun"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-020-09721-1","article-title":"Lymphatic MAFB regulates vascular patterning during developmental and pathological lymphangiogenesis","volume":"23","author":"Dieterich LC","year":"2020","unstructured":"Dieterich LC, Tacconi C, Menzi F, et al.. Lymphatic MAFB regulates vascular patterning during developmental and pathological lymphangiogenesis. Angiogenesis. 2020, 23:411-23. 10.1007\/s10456-020-09721-1","journal-title":"Angiogenesis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194859","article-title":"CD147 promotes tumor lymphangiogenesis in melanoma via PROX-1","volume":"13","author":"de Moura CR","year":"2021","unstructured":"de Moura CR, Landras A, Khayati F, et al.. CD147 promotes tumor lymphangiogenesis in melanoma via PROX-1. Cancers (Basel). 2021, 13:4859. 10.3390\/cancers13194859","journal-title":"Cancers (Basel)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-019-0169-4","article-title":"Loss of CYLD accelerates melanoma development and progression in the Tg(Grm1) melanoma mouse model","volume":"8","author":"de Jel MM","year":"2019","unstructured":"de Jel MM, Schott M, Lamm S, Neuhuber W, Kuphal S, Bosserhoff AK. Loss of CYLD accelerates melanoma development and progression in the Tg(Grm1) melanoma mouse model. Oncogenesis. 2019, 8:56. 10.1038\/s41389-019-0169-4","journal-title":"Oncogenesis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1667742","article-title":"Identification of novel, immune-mediating extracellular vesicles in human lymphatic effluent draining primary cutaneous melanoma","volume":"8","author":"Maus RL","year":"2019","unstructured":"Maus RL, Jakub JW, Hieken TJ, et al.. Identification of novel, immune-mediating extracellular vesicles in human lymphatic effluent draining primary cutaneous melanoma. Oncoimmunology. 2019, 8:e1667742. 10.1080\/2162402X.2019.1667742","journal-title":"Oncoimmunology"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12197","article-title":"Melanoma-derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes","volume":"11","author":"Leary N","year":"2022","unstructured":"Leary N, Walser S, He Y, et al.. Melanoma-derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes. J Extracell Vesicles. 2022, 11:e12197. 10.1002\/jev2.12197","journal-title":"J Extracell Vesicles"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14755","article-title":"Role of VEGFR-1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib","volume":"24","author":"Atzori MG","year":"2020","unstructured":"Atzori MG, Ceci C, Ruffini F, et al.. Role of VEGFR-1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib. J Cell Mol Med. 2020, 24:465-75. 10.1111\/jcmm.14755","journal-title":"J Cell Mol Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abe4362","article-title":"Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas","volume":"7","author":"Sasso MS","year":"2021","unstructured":"Sasso MS, Mitrousis N, Wang Y, et al.. Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas. Sci Adv. 2021, 7:10.1126\/sciadv.abe4362","journal-title":"Sci Adv"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13629","article-title":"Targeting the VEGF-C\/VEGFR3 axis suppresses slug-mediated cancer metastasis and stemness via inhibition of KRAS\/YAP1 signaling","volume":"8","author":"Yeh YW","year":"2017","unstructured":"Yeh YW, Cheng CC, Yang ST, et al.. Targeting the VEGF-C\/VEGFR3 axis suppresses slug-mediated cancer metastasis and stemness via inhibition of KRAS\/YAP1 signaling. Oncotarget. 2017, 8:5603-18. 10.18632\/oncotarget.13629","journal-title":"Oncotarget"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2019.03.008","article-title":"Stromal inflammatory cells are associated with poorer prognosis in primary cutaneous melanoma","volume":"88","author":"Yun SJ","year":"2019","unstructured":"Yun SJ, Liu S, Buckley M, et al.. Stromal inflammatory cells are associated with poorer prognosis in primary cutaneous melanoma. Hum Pathol. 2019, 88:78-86. 10.1016\/j.humpath.2019.03.008","journal-title":"Hum Pathol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15125","article-title":"DRG2 supports the growth of primary tumors and metastases of melanoma by enhancing VEGF-A expression","volume":"287","author":"Yoon NA","year":"2020","unstructured":"Yoon NA, Jung SJ, Choi SH, et al.. DRG2 supports the growth of primary tumors and metastases of melanoma by enhancing VEGF-A expression. FEBS J. 2020, 287:2070-86. 10.1111\/febs.15125","journal-title":"FEBS J"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000000802","article-title":"Chronic localized fibrosing leukocytoclastic vasculitis associated with lymphedema, intralymphatic and intravascular lymphocytosis, and chronic myelogenous leukemia: a case report of unilateral erythema elevatum diutinum","volume":"39","author":"Atallah J","year":"2017","unstructured":"Atallah J, Garces JC, Loayza E, Carlson JA. Chronic localized fibrosing leukocytoclastic vasculitis associated with lymphedema, intralymphatic and intravascular lymphocytosis, and chronic myelogenous leukemia: a case report of unilateral erythema elevatum diutinum. Am J Dermatopathol. 2017, 39:479-84. 10.1097\/DAD.0000000000000802","journal-title":"Am J Dermatopathol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000001567","article-title":"Unilateral periocular intralymphatic histiocytosis, associated with rosacea (Morbihan disease)","volume":"42","author":"Belousova IE","year":"2020","unstructured":"Belousova IE, Kastnerova L, Khairutdinov VR, Kazakov DV. Unilateral periocular intralymphatic histiocytosis, associated with rosacea (Morbihan disease). Am J Dermatopathol. 2020, 42:452-4. 10.1097\/DAD.0000000000001567","journal-title":"Am J Dermatopathol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.96101","article-title":"A type of human skin dendritic cell marked by CD5 is associated with the development of inflammatory skin disease","volume":"2","author":"Korenfeld D","year":"2017","unstructured":"Korenfeld D, Gorvel L, Munk A, et al.. A type of human skin dendritic cell marked by CD5 is associated with the development of inflammatory skin disease. JCI Insight. 2017, 2:e96101. 10.1172\/jci.insight.96101","journal-title":"JCI Insight"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48046-y","article-title":"Opposing roles of endothelial and leukocyte-expressed IL-7R\u03b1 in the regulation of psoriasis-like skin inflammation","volume":"9","author":"Vranova M","year":"2019","unstructured":"Vranova M, Friess MC, Jahromi NH, et al.. Opposing roles of endothelial and leukocyte-expressed IL-7R\u03b1 in the regulation of psoriasis-like skin inflammation. Sci Rep. 2019, 9:11714. 10.1038\/s41598-019-48046-y","journal-title":"Sci Rep"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1089\/lrb.2016.0040","article-title":"Predilection to dermato-lymphangio-adenitis in obstructive lymphedema of lower limbs depending on genetic polymorphisms at TNF\u03b1-308G>A, CCR2-190G>A, CD14-159C>T, TLR2 2029C>T, TLR4 1063A>G, TLR4 1363C>T, TGF\u03b2 74G>C, and TGF\u03b2 29T>C","volume":"16","author":"Olszewski WL","year":"2018","unstructured":"Olszewski WL, Zagozda M, Zaleska MT, Durlik M. Predilection to dermato-lymphangio-adenitis in obstructive lymphedema of lower limbs depending on genetic polymorphisms at TNF\u03b1-308G>A, CCR2-190G>A, CD14-159C>T, TLR2 2029C>T, TLR4 1063A>G, TLR4 1363C>T, TGF\u03b2 74G>C, and TGF\u03b2 29T>C. Lymphat Res Biol. 2018, 16:109-16. 10.1089\/lrb.2016.0040","journal-title":"Lymphat Res Biol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00006","article-title":"Extracellular vesicles released from the skin commensal yeast Malassezia sympodialis activate human primary keratinocytes","volume":"10","author":"Vallhov H","year":"2020","unstructured":"Vallhov H, Johansson C, Veerman RE, Scheynius A. Extracellular vesicles released from the skin commensal yeast Malassezia sympodialis activate human primary keratinocytes. Front Cell Infect Microbiol. 2020, 10:6. 10.3389\/fcimb.2020.00006","journal-title":"Front Cell Infect Microbiol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2111726119","article-title":"Lymph-derived chemokines direct early neutrophil infiltration in the lymph nodes upon Staphylococcus aureus skin infection","volume":"119","author":"Xue J","year":"2022","unstructured":"Xue J, Lin Y, Oo D, et al.. Lymph-derived chemokines direct early neutrophil infiltration in the lymph nodes upon Staphylococcus aureus skin infection. Proc Natl Acad Sci U S A. 2022, 119:e2111726119. 10.1073\/pnas.2111726119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113833","article-title":"Physiological models for in vivo imaging and targeting the lymphatic system: Nanoparticles and extracellular vesicles","volume":"175","author":"Olmeda D","year":"2021","unstructured":"Olmeda D, Cerezo-Wallis D, Castellano-Sanz E, Garc\u00eda-Silva S, Peinado H, Soengas MS. Physiological models for in vivo imaging and targeting the lymphatic system: Nanoparticles and extracellular vesicles. Adv Drug Deliv Rev. 2021, 175:113833. 10.1016\/j.addr.2021.113833","journal-title":"Adv Drug Deliv Rev"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16757","article-title":"Dietary oleuropein inhibits tumor angiogenesis and lymphangiogenesis in the B16F10 melanoma allograft model: a mechanism for the suppression of high-fat diet-induced solid tumor growth and lymph node metastasis","volume":"8","author":"Song H","year":"2017","unstructured":"Song H, Lim DY, Jung JI, et al.. Dietary oleuropein inhibits tumor angiogenesis and lymphangiogenesis in the B16F10 melanoma allograft model: a mechanism for the suppression of high-fat diet-induced solid tumor growth and lymph node metastasis. Oncotarget. 2017, 8:32027-42. 10.18632\/oncotarget.16757","journal-title":"Oncotarget"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1111\/srt.13405","article-title":"The effect of secukinumab treatment for psoriasis on serum cytokines and correlation with disease severity","volume":"29","author":"Wu LT","year":"2023","unstructured":"Wu LT, Qiao ZH, Tian JB, Lin JL, Hou SC, Liu XM. The effect of secukinumab treatment for psoriasis on serum cytokines and correlation with disease severity. Skin Res Technol. 2023, 29:e13405. 10.1111\/srt.13405","journal-title":"Skin Res Technol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13428","article-title":"IL-35 recombinant protein reverses inflammatory bowel disease and psoriasis through regulation of inflammatory cytokines and immune cells","volume":"22","author":"Wang Y","year":"2018","unstructured":"Wang Y, Mao Y, Zhang J, et al.. IL-35 recombinant protein reverses inflammatory bowel disease and psoriasis through regulation of inflammatory cytokines and immune cells. J Cell Mol Med. 2018, 22:1014-25. 10.1111\/jcmm.13428","journal-title":"J Cell Mol Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S406649","article-title":"Gentiopicroside-loaded chitosan nanoparticles inhibit TNF-\u03b1-induced proliferation and inflammatory response in HaCaT keratinocytes and ameliorate imiquimod-induced dermatitis lesions in mice","volume":"18","author":"Zhao K","year":"2023","unstructured":"Zhao K, Pu S, Sun L, Zhou D. Gentiopicroside-loaded chitosan nanoparticles inhibit TNF-\u03b1-induced proliferation and inflammatory response in HaCaT keratinocytes and ameliorate imiquimod-induced dermatitis lesions in mice. Int J Nanomedicine. 2023, 18:3781-800. 10.2147\/IJN.S406649","journal-title":"Int J Nanomedicine"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/323894-an-update-on-the-role-of-lymphatic-function-in-skin-inflammatory-disorders-a-scoping-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T20:02:19Z","timestamp":1737835339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/323894-an-update-on-the-role-of-lymphatic-function-in-skin-inflammatory-disorders-a-scoping-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,25]]},"references-count":45,"URL":"https:\/\/doi.org\/10.7759\/cureus.77981","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,25]]}}}